Cyclarity Therapeutics, Inc. — Form D
Cyclarity Therapeutics, Inc. of Novato, CA, a company, filed a Form D exempt-offering notice with the SEC on 2019-11-25. The offering totals $4.0M, of which $1.5M was reported sold. Industry: Pharmaceuticals.
Offering
- Filed: 2019-11-25
- Form: D
- Accession: 0001794705-19-000001
- Industry: Pharmaceuticals
- Exemptions: 06b
- Total offering: $4.0M
- Amount sold: $1.5M
- Remaining: $2.5M
- Investors: 9
- Date of first sale: 2019-11-12
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-354186
Issuer
- Name: Cyclarity Therapeutics, Inc.
- CIK: 0001794705
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2019
- Address: 8001 Redwood Blvd, Novato, CA, 94945
- Phone: 6509065631
Officers, directors & promoters (5)
| Name | Role | Location |
|---|
| Matthew O'Connor | Director | Austin, TX |
| Matthew O'Connor | Executive Officer | Austin, TX |
| Michael Kope | Director | Novato, CA |
| Michael Kope | Executive Officer | Novato, CA |
| Frank Schueler | Director | Mountain View, CA |
Other filings by this issuer (2)
More